Applied Therapeutics (APLT) Short Interest Ratio & Short Volume → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free APLT Stock Alerts $4.76 +0.23 (+5.08%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Applied Therapeutics Short Interest DataCurrent Short Volume4,740,000 sharesPrevious Short Volume4,980,000 sharesChange Vs. Previous Month-4.82%Dollar Volume Sold Short$23.98 millionShort Interest Ratio / Days to Cover2.6Last Record DateApril 15, 2024Outstanding Shares114,242,000 sharesPercentage of Shares Shorted4.15%Today's Trading Volume622,610 sharesAverage Trading Volume729,569 sharesToday's Volume Vs. Average85% Short Selling Applied Therapeutics ? Sign up to receive the latest short interest report for Applied Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPLT Short Interest Over TimeAPLT Days to Cover Over TimeAPLT Percentage of Float Shorted Over Time Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. Applied Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,740,000 shares $23.98 million -4.8%N/A2.6 $5.06 3/31/20244,980,000 shares $33.86 million +31.4%N/A2.4 $6.80 3/15/20243,790,000 shares $22.82 million -12.5%N/A1.8 $6.02 2/29/20244,330,000 shares $30.83 million +11.9%N/A1.9 $7.12 2/15/20243,870,000 shares $14.51 million +4.3%N/A2 $3.75 1/31/20243,710,000 shares $11.61 million +2.2%N/A2.7 $3.13 Get the Latest News and Ratings for APLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,630,000 shares $9.08 million +83.3%N/A2.8 $2.50 12/31/20231,980,000 shares $6.63 million -7.5%N/A1.5 $3.35 12/15/20232,140,000 shares $6.33 million -37.1%N/A2.1 $2.96 11/30/20233,400,000 shares $7.17 million +71.7%N/A3.2 $2.11 11/15/20231,980,000 shares $4.22 million +2.6%N/A2 $2.13 10/31/20231,930,000 shares $4.63 million +27.0%N/A2.1 $2.40 10/15/20231,520,000 shares $3.68 million +49.0%N/A1.6 $2.42 9/30/20231,020,000 shares $2.54 million -55.5%N/A1.4 $2.49 9/15/20232,290,000 shares $4.26 million +54.7%N/A3.6 $1.86 8/31/20231,480,000 shares $1.97 million -3.3%N/A3.6 $1.33 8/15/20231,530,000 shares $2.05 million +39.1%N/A6.4 $1.34 7/31/20231,100,000 shares $1.96 million No ChangeN/A4.5 $1.78 7/15/20231,100,000 shares $1.52 million +0.9%N/A2.8 $1.38 6/30/20231,090,000 shares $1.40 million +9.1%N/A2.7 $1.28 6/15/2023999,000 shares $1.43 million +13.5%N/A2.4 $1.43 5/31/2023880,000 shares $1.14 million +48.1%N/A2.2 $1.29 5/15/2023594,400 shares $855,936.00 -18.2%N/A1.5 $1.44 4/30/2023726,400 shares $1.23 million +107.4%N/A1.6 $1.70 4/15/2023350,200 shares $292,767.20 -21.0%N/A1.1 $0.84 3/31/2023443,300 shares $359,560.63 +6.3%N/A1.8 $0.81 3/15/2023417,000 shares $371,130.00 -17.3%N/A1.5 $0.89 2/28/2023504,100 shares $509,141.00 +32.2%N/A1.8 $1.01 2/15/2023381,300 shares $381,300.00 -3.3%N/A1.2 $1.00 1/31/2023394,100 shares $437,451.00 +8.8%N/A1.3 $1.11 1/15/2023362,200 shares $340,468.00 +70.9%N/A1.2 $0.94 12/30/2022211,900 shares $161,044.00 -34.3%N/A0.6 $0.76 12/15/2022322,600 shares $275,823.00 +29.7%N/A0.9 $0.86 11/30/2022248,800 shares $278,656.00 -6.6%N/A0.7 $1.12 11/15/2022266,400 shares $226,120.32 +14.4%N/A0.8 $0.85 10/31/2022232,800 shares $180,187.20 -11.0%N/A0.7 $0.77 10/15/2022261,500 shares $161,084.00 +24.8%N/A0.8 $0.62 9/30/2022209,600 shares $194,948.96 -1.1%N/A0.8 $0.93 9/15/2022212,000 shares $313,760.00 -9.4%N/A0.5 $1.48 8/31/2022234,000 shares $320,580.00 -2.3%N/A0.5 $1.37FW: 234x Gain (Ad)This coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. APLT Short Interest - Frequently Asked Questions What is Applied Therapeutics' current short interest? Short interest is the volume of Applied Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 4,740,000 shares of APLT short. Learn More on Applied Therapeutics' current short interest. What is a good short interest ratio for Applied Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APLT shares currently have a short interest ratio of 3.0. Learn More on Applied Therapeutics's short interest ratio. Which institutional investors are shorting Applied Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Applied Therapeutics: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Applied Therapeutics' short interest increasing or decreasing? Applied Therapeutics saw a decrease in short interest in April. As of April 15th, there was short interest totaling 4,740,000 shares, a decrease of 4.8% from the previous total of 4,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Applied Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Applied Therapeutics: Astria Therapeutics, Inc. (11.33%), Verve Therapeutics, Inc. (28.64%), Adlai Nortye Ltd. (0.02%), Shattuck Labs, Inc. (4.42%), Arbutus Biopharma Co. (2.88%), Avid Bioservices, Inc. (16.26%), Phathom Pharmaceuticals, Inc. (43.45%), Oculis Holding AG (0.13%), COMPASS Pathways plc (5.39%), KalVista Pharmaceuticals, Inc. (13.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Applied Therapeutics stock? Short selling APLT is an investing strategy that aims to generate trading profit from Applied Therapeutics as its price is falling. APLT shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Applied Therapeutics? A short squeeze for Applied Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APLT, which in turn drives the price of the stock up even further. How often is Applied Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Astria Therapeutics Short Interest Verve Therapeutics Short Interest Adlai Nortye Short Interest Shattuck Labs Short Interest Arbutus Biopharma Short Interest Avid Bioservices Short Interest Phathom Pharmaceuticals Short Interest Oculis Short Interest COMPASS Pathways Short Interest KalVista Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APLT) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits